Newsletter Signup | Join Community
Lymphoma patients & transplant recipients have suppressed immune systems and an increased risk of developing melanoma.
Follicular - low grade lymphomas, and CLL can "transform" into higher grade lymphomas requiring a change in treatment.
Rituxan maintenance is standard treatment of follicular & mantle cell lymphoma; should it be given every 2 or 3 months?
Cancer Connect - Stages IIE - IV Aggressive Non Hodgkins Lymphoma
BR is effective treatment for Follicular, Indolent and Mantle cell Non-Hodgkin’s Lymphoma.
HDC and ASCT is the standard of care for treatment of several types of lymphomas in a variety of situations.
Symptoms, diagnosis, and treatment of Mantle Cell Lymphoma: Study suggests BR may be new standard initial treatment.
Stem cell transplant, CAR T cells and newer precision cancer medicines are all improving the outcomes for recurrent NHL
Overview of Autologous Stem Cell Transplant for treatment of Burkitts, small cleaved and highly aggressive NHL
Follicular - low grade lymphomas that require treatment appear to benefit most from Treanda-Rituxan.
How long have people been on watch and wait before they needed treatment ?
Rituxan Maintenance; has your doctor recommended it every 2 or every 3 months?
Long-Term Follow-Up Indicates Survival with Addition of Rituxan® to CHOP in NHL
Curious is others with celiac disease have develeoped lymphoma? https://mavendoctors…